Ajanta Pharma confirms IT Department search; says process still underway

Published On 2025-08-21 12:43 GMT   |   Update On 2025-08-21 12:43 GMT

IT Dept searches Akums Drugs, it subsidiaries offices

Advertisement

Mumbai: Ajanta Pharma Limited has informed on BSE that the Income Tax Department conducted a search at some of its offices and manufacturing units on August 19, 2025, under the Income Tax Act, 1961. The search proceedings are currently ongoing.

The company said it is fully cooperating with the officials and providing all clarifications and details sought. "We will continue to provide any further clarification /information that may be required," it added.

It assured that business operations have continued as usual and remain unaffected by the search.

Ajanta Pharma also dismissed social media rumours. The company clarified that the significant movement observed in the price of its shares across exchanges in the recent past is “purely market-driven.”

Read also: Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside

Ajanta Pharma is a speciality pharmaceutical formulation company having major focus on branded generic business across India, Asia & Africa. The company has a ground presence in each of these 30+ countries.

Advertisement

The company’s state-of-the-art R&D centre is located in Mumbai. The company has 7 world-class manufacturing facilities located in India.

Read also: Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News